139 related articles for article (PubMed ID: 18059332)
1. A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma.
Chang CL; Hong E; Lao-Sirieix P; Fitzgerald RC
Oncogene; 2008 May; 27(21):2951-60. PubMed ID: 18059332
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid-induced glandular differentiation of the oesophagus.
Chang CL; Lao-Sirieix P; Save V; De La Cueva Mendez G; Laskey R; Fitzgerald RC
Gut; 2007 Jul; 56(7):906-17. PubMed ID: 17185354
[TBL] [Abstract][Full Text] [Related]
3. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
[TBL] [Abstract][Full Text] [Related]
4. Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma.
Barclay JY; Morris A; Nwokolo CU
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):221-7. PubMed ID: 15674101
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
6. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
Lord RV; Salonga D; Danenberg KD; Peters JH; DeMeester TR; Park JM; Johansson J; Skinner KA; Chandrasoma P; DeMeester SR; Bremner CG; Tsai PI; Danenberg PV
J Gastrointest Surg; 2000; 4(2):135-42. PubMed ID: 10675236
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma.
Clemons NJ; Shannon NB; Abeyratne LR; Walker CE; Saadi A; O'Donovan ML; Lao-Sirieix PP; Fitzgerald RC
Carcinogenesis; 2010 Sep; 31(9):1669-75. PubMed ID: 20584750
[TBL] [Abstract][Full Text] [Related]
8. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
Ozpolat B; Mehta K; Lopez-Berestein G
Leuk Lymphoma; 2005 Oct; 46(10):1497-506. PubMed ID: 16194896
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a novel retinoic acid response element in zebrafish cyp26a1 promoter.
Li J; Hu P; Li K; Zhao Q
Anat Rec (Hoboken); 2012 Feb; 295(2):268-77. PubMed ID: 22190473
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional co-operativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility.
Loudig O; Maclean GA; Dore NL; Luu L; Petkovich M
Biochem J; 2005 Nov; 392(Pt 1):241-8. PubMed ID: 16053444
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma.
Lagorce C; Paraf F; Vidaud D; Couvelard A; Wendum D; Martin A; Fléjou JF
Histopathology; 2003 May; 42(5):457-65. PubMed ID: 12713622
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte nuclear factor 4α (HNF4α) in coordination with retinoic acid receptors increases all-trans-retinoic acid-dependent CYP26A1 gene expression in HepG2 human hepatocytes.
Zolfaghari R; Ross AC
J Cell Biochem; 2014 Oct; 115(10):1740-51. PubMed ID: 24819304
[TBL] [Abstract][Full Text] [Related]
13. CYP26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid.
Langton S; Gudas LJ
Dev Biol; 2008 Mar; 315(2):331-54. PubMed ID: 18241852
[TBL] [Abstract][Full Text] [Related]
14. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.
Peng DF; Razvi M; Chen H; Washington K; Roessner A; Schneider-Stock R; El-Rifai W
Gut; 2009 Jan; 58(1):5-15. PubMed ID: 18664505
[TBL] [Abstract][Full Text] [Related]
15. Retinoid regulation of the zebrafish cyp26a1 promoter.
Hu P; Tian M; Bao J; Xing G; Gu X; Gao X; Linney E; Zhao Q
Dev Dyn; 2008 Dec; 237(12):3798-808. PubMed ID: 19035346
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett's oesophagus and adenocarcinoma.
Crispino P; Alò PL; Rivera M; Barillà D; Nardi F; Mariotti M; Giancarlo Z; Botti C; Pica R; Cassieri C; Unim H; Paoluzi P
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1533-41. PubMed ID: 19471962
[TBL] [Abstract][Full Text] [Related]
17. Aurora kinase A in Barrett's carcinogenesis.
Rugge M; Fassan M; Zaninotto G; Pizzi M; Giacomelli L; Battaglia G; Rizzetto C; Parente P; Ancona E
Hum Pathol; 2010 Oct; 41(10):1380-6. PubMed ID: 20656315
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1.
Osanai M; Sawada N; Lee GH
Oncogene; 2010 Feb; 29(8):1135-44. PubMed ID: 19935721
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis.
Lee OJ; Schneider-Stock R; McChesney PA; Kuester D; Roessner A; Vieth M; Moskaluk CA; El-Rifai W
Neoplasia; 2005 Sep; 7(9):854-61. PubMed ID: 16229808
[TBL] [Abstract][Full Text] [Related]
20. Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma.
Sonoda R; Naomoto Y; Shirakawa Y; Fujiwara Y; Yamatsuji T; Noma K; Tanabe S; Takaoka M; Gunduz M; Tsujigiwa H; Nagatsuka H; Ohara N; Yoshino T; Takubo K; Vieth M; Tanaka N
Histopathology; 2010 Jul; 57(1):90-100. PubMed ID: 20653782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]